Combining sodium-glucose co-transporter-2 inhibitor with mesenchymal stem cells and brown adipose tissue (BAT) and white adipose tissue (WAT) transplantation to mitigate the progression of diabetic kidney disease: a pre-clinical approach
Stephany Beyerstedt(Hospital Israelita Albert Einstein), Érika Bevilaqua Rangel(Hospital Israelita Albert Einstein)
Cited by 2
Related Papers
COVID-19: angiotensin-converting enzyme 2 (ACE2) expression and tissue susceptibility to SARS-CoV-2 infection
|European Journal of Clinical Microbiology & Infectious Diseases|2021|900
Kidney-derived c-kit+ progenitor/stem cells contribute to podocyte recovery in a model of acute proteinuria
|Scientific Reports|2018|24